HAEMATO AG, DE0006190705

HAEMATO AG, DE0006190705

18.05.2018 - 13:12:37

HAEMATO AG - IFRS Results Q1 2018

HAEMATO AG - IFRS Results Q1 2018   HAEMATO AG is a listed pharmaceutical company focusing on the growth markets of high-priced special pharmaceuticals from the indication areas oncology and HIV as well as in the areas of rheumatism, neurology and cardiovascular diseases. In addition, the company started its own development of innovative medical products for the beauty market. HAEMATO AG assumes that the first products will come onto the market next year, which has already created the basis for further growth and additional earnings.

HAEMATO AG, Berlin (ISIN: DE0006190705), achieved IFRS consolidated sales of EUR 69.8 million (previous year: EUR 68.0 million) and an operating result (EBIT) of EUR 4.0 million in the first quarter of 2018. Sales increased by 2.8% compared to the same period of the previous year. The Executive Board is optimistic that it will achieve the targets set for the 2018 financial year.

About HAEMATO:

HAEMATO AG, founded in 1993, is a pharmaceutical company. The focus of business activities is on the growth markets of high-priced special pharmaceuticals. The focus is on therapies for cancer, HIV and other chronic diseases.

HAEMATO AG is listed on the Basic Board (Open Market) of the Frankfurt Stock Exchange. Key figures for the HAEMATO AG share: Subscribed capital: EUR 21,980,000 Listed class of share: Bearer shares ISIN: DE0006190705 * WKN: 619070 * Ticker symbol: HAE

Contact: HAEMATO AG, Investor Relations Telefon: +49 (0)30 897 30 86 70 ir@haemato.de

18.05.2018 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language: English Company: HAEMATO AG Lilienthalstraße 5c 12529 Schönefeld

Germany Phone: +49 (0)30 897 30 86 70 Fax: +49 (0)30 897 30 86 79 E-mail: ir@haemato.de Internet: www.haemato.de ISIN: DE0006190705 WKN: 619070 Listed: Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Basic Board), Hamburg, Stuttgart, Tradegate Exchange   End of News DGAP News Service

687669  18.05.2018 

@ dgap.de

Amazon wird sich schwarzärgern, aber …

… wir schenken Ihnen den Report „Börsenpsychologie - Markttechnik für Trader“ heute trotzdem kostenfrei. Normalerweise kostet der Report im Onlinehandel 39,99 Euro.

Sie können sich den genialen Report heute jedoch absolut kostenfrei sichern. Wir senden Ihnen den Report vollkommen KOSTENFREI zu.

Jetzt HIER klicken und dank richtigen Timing reich an der Börse werden!